Correction: Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial

Detalles Bibliográficos
Autores principales: Bailey, Clifford J, Gross, Jorge L, Hennicken, Delphine, Iqbal, Nayyar, Mansfield, Traci A, List, James F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820155/
http://dx.doi.org/10.1186/1741-7015-11-193
_version_ 1782290092718555136
author Bailey, Clifford J
Gross, Jorge L
Hennicken, Delphine
Iqbal, Nayyar
Mansfield, Traci A
List, James F
author_facet Bailey, Clifford J
Gross, Jorge L
Hennicken, Delphine
Iqbal, Nayyar
Mansfield, Traci A
List, James F
author_sort Bailey, Clifford J
collection PubMed
description
format Online
Article
Text
id pubmed-3820155
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38201552013-11-11 Correction: Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial Bailey, Clifford J Gross, Jorge L Hennicken, Delphine Iqbal, Nayyar Mansfield, Traci A List, James F BMC Med Correction BioMed Central 2013-09-02 /pmc/articles/PMC3820155/ http://dx.doi.org/10.1186/1741-7015-11-193 Text en Copyright © 2013 Bailey et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Correction
Bailey, Clifford J
Gross, Jorge L
Hennicken, Delphine
Iqbal, Nayyar
Mansfield, Traci A
List, James F
Correction: Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial
title Correction: Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial
title_full Correction: Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial
title_fullStr Correction: Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial
title_full_unstemmed Correction: Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial
title_short Correction: Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial
title_sort correction: dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820155/
http://dx.doi.org/10.1186/1741-7015-11-193
work_keys_str_mv AT baileycliffordj correctiondapagliflozinaddontometforminintype2diabetesinadequatelycontrolledwithmetforminarandomizeddoubleblindplacebocontrolled102weektrial
AT grossjorgel correctiondapagliflozinaddontometforminintype2diabetesinadequatelycontrolledwithmetforminarandomizeddoubleblindplacebocontrolled102weektrial
AT hennickendelphine correctiondapagliflozinaddontometforminintype2diabetesinadequatelycontrolledwithmetforminarandomizeddoubleblindplacebocontrolled102weektrial
AT iqbalnayyar correctiondapagliflozinaddontometforminintype2diabetesinadequatelycontrolledwithmetforminarandomizeddoubleblindplacebocontrolled102weektrial
AT mansfieldtracia correctiondapagliflozinaddontometforminintype2diabetesinadequatelycontrolledwithmetforminarandomizeddoubleblindplacebocontrolled102weektrial
AT listjamesf correctiondapagliflozinaddontometforminintype2diabetesinadequatelycontrolledwithmetforminarandomizeddoubleblindplacebocontrolled102weektrial

Ejemplares similares